Findings of a Phase III Clinical Study of Sanbexin® Sub

/PRNewswire/ -- On February 19, 2024, the Journal of American Medical Association•Neurology (JAMA NEUROLOGY, IF: 29.0) published online the key findings of a...

Related Keywords

Nanjing , Jiangsu , China , United States , Dongsheng , Jilin , Peking , Beijing , American , Wang Yongjun , Neurodawn Pharmaceutical Co Ltd , Simcere Pharmaceutical Group , Tiantan Hospital Of Capital Medical University , National Medical Products Administration Of China , Simcere Pharmaceutical Group Ltd , University Third Hospital , Journal Of American Medical Association , American Medical Association , Dexborneol Concentrated Solution , New Drug Application , National Medical Products Administration , Beijing Tiantan Hospital , Capital Medical University , Fan Dongsheng , Peking University Third Hospital , Pharmaceutical Group , Simcere Pharmaceutical Group Limited , Pharmaceuticals , Health Care Amp Hospitals , Medical Pharmaceuticals , Biotechnology , Clinical Trials Amp Medical Discoveries ,